{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:10:08Z","timestamp":1783825808494,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.mce.2021.111243","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:27:04Z","timestamp":1615512424000},"page":"111243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Inhibition of Aurora kinase A activity enhances the antitumor response of beta-catenin blockade in human adrenocortical cancer cells"],"prefix":"10.1016","volume":"528","author":[{"given":"Andrea Gutierrez","family":"Maria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleiton","family":"Silva Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.P.","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Hassib Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5576-9525","authenticated-orcid":false,"given":"Annabel","family":"Berthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-0947","authenticated-orcid":false,"given":"Ludivine","family":"Drougat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Kiseljak-Vassiliades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Wierman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio R.","family":"Faucz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Marcel","family":"Fa\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Gonzaga","family":"Tone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"51","key":"10.1016\/j.mce.2021.111243_bib1","doi-asserted-by":"crossref","first-page":"84634","DOI":"10.18632\/oncotarget.12382","article-title":"Unraveling the expression of the oncogene YAP1, a Wnt\/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients","volume":"7","author":"Abduch","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.mce.2021.111243_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.mce.2021.111243_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.mce.2021.111243_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00018-019-03310-2","article-title":"Insights into the non-mitotic functions of Aurora kinase A: more than just cell division","volume":"77","author":"Bertolin","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.mce.2021.111243_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/pbc.24653","article-title":"Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): overexpression of Aurora kinases A and B is associated with a poor prognosis","volume":"60","author":"Borges","year":"2013","journal-title":"Pediatr. Blood Canc."},{"issue":"6","key":"10.1016\/j.mce.2021.111243_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CAD.0000000000000504","article-title":"The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line","volume":"28","author":"Borges","year":"2017","journal-title":"Anti Canc. Drugs"},{"issue":"30","key":"10.1016\/j.mce.2021.111243_bib7","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1038\/s41388-020-1358-5","article-title":"Wnt\/\u03b2-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice","volume":"39","author":"Borges","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2021.111243_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.08.045","article-title":"A comprehensive review on Aurora kinase: small molecule inhibitors and clinical trial studies","volume":"140","author":"Borisa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.mce.2021.111243_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.mce.2021.111243_bib10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/cncr.31916","article-title":"The who, when, and why of primary adrenal malignancies: insights into the epidemiology of a rare clinical entity","volume":"125","author":"Chandrasekar","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Canc. Res."},{"issue":"9","key":"10.1016\/j.mce.2021.111243_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma - towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.mce.2021.111243_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.tips.2017.05.003","article-title":"Aurora A kinase is a priority pharmaceutical target for the treatment of cancers","volume":"38","author":"Damodaran","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.mce.2021.111243_bib14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","article-title":"Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival","volume":"27","author":"de Reyni\u00e8s","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.mce.2021.111243_bib15","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1210\/jc.2008-0247","article-title":"The T cell factor\/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells","volume":"93","author":"Doghman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2021.111243_bib16","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055743","article-title":"Silencing mutated \u03b2-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R","volume":"8","author":"Gaujoux","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.mce.2021.111243_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/jcm8081092","article-title":"Markers of cancer cell invasion: are they good enough?","volume":"8","author":"Gerashchenko","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.onc.1208279","article-title":"Polo kinase and progression through M phase in Drosophila: a perspective from the spindle poles","volume":"24","author":"Glover","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mce.2021.111243_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mce.2021.111243_bib21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mce.2021.111243_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1515\/hsz-2017-0304","article-title":"Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt\/\u03b2-catenin signaling pathway and the epithelial-mesenchymal transition process","volume":"399","author":"He","year":"2018","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.mce.2021.111243_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-013-2702-z","article-title":"AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53","volume":"141","author":"Kalous","year":"2013","journal-title":"Breast Canc. Res. Treat."},{"issue":"12","key":"10.1016\/j.mce.2021.111243_bib24","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1210\/jc.2013-2281","article-title":"Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma","volume":"98","author":"Kerkhofs","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2021.111243_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/ERC-17-0447","article-title":"Development of new preclinical models to advance adrenocortical carcinoma research","volume":"25","author":"Kiseljak-Vassiliades","year":"2018","journal-title":"Endocr. Relat. Canc."},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib26","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/ERC-17-0440","article-title":"The next step: mechanisms driving adrenocortical carcinoma metastasis","volume":"25","author":"Lalli","year":"2018","journal-title":"Endocr. Relat. Canc."},{"issue":"40","key":"10.1016\/j.mce.2021.111243_bib27","doi-asserted-by":"crossref","first-page":"43016","DOI":"10.18632\/oncotarget.5513","article-title":"Inhibition of the Tcf\/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis","volume":"6","author":"Leal","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.mce.2021.111243_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13543784.2018.1417382","article-title":"Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors","volume":"27","author":"Liewer","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"4","key":"10.1016\/j.mce.2021.111243_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"12","key":"10.1016\/j.mce.2021.111243_bib30","first-page":"1377","article-title":"Aurora kinase A inhibitors: promising agents in antitumoral therapy","volume":"18","author":"Malumbres","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.mce.2021.111243_bib31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/js.2018-00197","article-title":"Therapeutic targets for adrenocortical carcinoma in the genomics era","volume":"2","author":"Mohan","year":"2018","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib32","first-page":"62","article-title":"Role of mitotane in adrenocortical carcinoma - review and state of the art","volume":"14","author":"Paragliola","year":"2018","journal-title":"Eur. Endocrinol."},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib33","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/EJE-17-0976","article-title":"Mechanisms OF endocrinology: cell cycle regulation in adrenocortical carcinoma","volume":"179","author":"Pereira","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.mce.2021.111243_bib34","doi-asserted-by":"crossref","first-page":"107524","DOI":"10.1016\/j.celrep.2020.107524","article-title":"Beta-catenin causes adrenal hyperplasia by blocking zonal transdifferentiation","volume":"31","author":"Pignatti","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.mce.2021.111243_bib35","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1530\/JME-18-0122","article-title":"Pathobiology and genetics of adrenocortical carcinoma","volume":"62","author":"Pittaway","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2021.111243_bib36","doi-asserted-by":"crossref","first-page":"1\u201012","DOI":"10.1016\/j.cancergen.2018.10.005","article-title":"Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature","volume":"230","author":"Rahane","year":"2019","journal-title":"Cancer Genet"},{"key":"10.1016\/j.mce.2021.111243_bib37","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/bioinformatics\/btr355","article-title":"Identification of novel transcripts in annotated genomes using RNA-Seq","volume":"27","author":"Roberts","year":"2011","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.mce.2021.111243_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-3-r22","article-title":"Improving RNA-Seq expression estimates by correcting for fragment bias","volume":"12","author":"Roberts","year":"2011","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.mce.2021.111243_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40618-019-01127-1","article-title":"The effects of mitotane and 1\u03b1,25-dihydroxyvitamin D3 on Wnt\/beta-catenin signaling in human adrenocortical carcinoma cells","volume":"43","author":"Rubin","year":"2020","journal-title":"J. Endocrinol. Invest."},{"issue":"13","key":"10.1016\/j.mce.2021.111243_bib40","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.18632\/oncotarget.3222","article-title":"Loss of \u03b2-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition","volume":"6","author":"Salomon","year":"2015","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.mce.2021.111243_bib41","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.18632\/oncotarget.15687","article-title":"The regulation of \u03b2-catenin activity and function in cancer: therapeutic opportunities","volume":"8","author":"Shang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.mce.2021.111243_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.surg.2018.04.080","article-title":"Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma","volume":"165","author":"Subramanian","year":"2019","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.mce.2021.111243_bib44","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tips.2016.04.006","article-title":"Exosome-mediated metastasis: from epithelial-mesenchymal transition to escape from immunosurveillance","volume":"37","author":"Syn","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mce.2021.111243_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.critrevonc.2017.09.006","article-title":"Critical risk-benefit assessment of the novel anti-cancer aurora a kinase inhibitor alisertib (MLN8237): a comprehensive review of the clinical data","volume":"119","author":"Tayyar","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mce.2021.111243_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.mce.2021.111243_bib47","article-title":"The functional diversity of Aurora kinases: a comprehensive review","volume":"13","author":"Willems","year":"2018","journal-title":"Cell Div."},{"issue":"1","key":"10.1016\/j.mce.2021.111243_bib48","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/s41598-017-02623-1","article-title":"Inhibition of AURKA kinase activity suppresses collective invasion in a microfluidic cell culture platform","volume":"7","author":"Xia","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.mce.2021.111243_bib49","doi-asserted-by":"crossref","first-page":"151\u2010161","DOI":"10.14740\/wjon1062w","article-title":"The effect of aurora kinase inhibitor on adhesion and migration in human breast cancer cells and clinical implications","volume":"8","author":"Zhao","year":"2017","journal-title":"World J. Oncol."},{"issue":"5","key":"10.1016\/j.mce.2021.111243_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma [published correction appears in cancer cell. 2016 Aug 8;30(2):363]","volume":"29","author":"Zheng","year":"2016","journal-title":"Canc. Cell"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720721000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:16:28Z","timestamp":1759587388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720721000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"alternative-id":["S0303720721000873"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111243","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Aurora kinase A activity enhances the antitumor response of beta-catenin blockade in human adrenocortical cancer cells","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111243"}}